Health Trials

Salmonella Infections

2

Review clinical trials related to Salmonella Infections. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults

The current clinical study will evaluate the GVGH Quadrivalent Pan-Salmonella vaccine for the first time in healthy adults in Africa. The purpose of the current Phase 1 study is to evaluate the safety, reactogenicity, and the immune response induced by the Pan-Salmonella vaccine.

Participants needed: 196
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: GlaxoSmithKlineUpdated: Jun 23, 2026
Eligibility criteria

Participants who, in the opinion of the Investigator, can and will comply with t... [+10]

Known exposure to S. Typhi, S. Paratyphi A, and non-typhoidal Salmonella confirm... [+21]

Read more
Status: Recruiting

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

The purpose of this study is to evaluate the safety, reactogenicity, and immune response induced by the GlaxoSmithKline Biologicals SA (GSK) Vaccines Institute for Global Health (GVGH) invasive nontyphoidal Salmonella-typhoid conjugate (iNTS-TCV) vaccine in infants with the first dose administered at 6 months of age (MOA) or 6 weeks of age (WOA).

Participants needed: 537
Trial details
Phase: Phase 2Age: 6-6Biological sex: AllType: InterventionalSponsor: GlaxoSmithKlineUpdated: Apr 20, 2026Locations: 1
Eligibility criteria

Have signed/thumb-printed, voluntary, informed consent provided for them by thei... [+9]

Have had a known infection with STm, SEn or S. Typhi. [+30]

Read more